7,538
Views
10
CrossRef citations to date
0
Altmetric
Gastroenterology

Efficacy and safety of oral Pentasa (prolonged-release mesalazine) in mild-to-moderate ulcerative colitis: a systematic review and meta-analysis

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1891-1900 | Received 24 Jul 2021, Accepted 12 Aug 2021, Published online: 01 Sep 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yilin Li, Tingting Wang, Beibei Ma, Shangyue Yu, Hailuan Pei, Shiqiu Tian, Yingying Tian, Chuang Liu, Xinyue Zhao, Zeping Zuo & Zhibin Wang. (2023) Xianglian Zhixie Tablet Antagonizes Dextran Sulfate Sodium-Induced Ulcerative Colitis by Attenuating Systemic Inflammation and Modulating Gut Microbiota. Journal of Inflammation Research 16, pages 4331-4346.
Read now
Axel U. Dignass, Kristine Paridaens, Sameer Al Awadhi, Jakob Begun, Jae Hee Cheon, John R. Fullarton, Edouard Louis, Fernando Magro, Juan Ricardo Marquez, Alexander R. Moschen, Neeraj Narula, Grazyna Rydzewska & Simon P. L. Travis. (2022) Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis. Scandinavian Journal of Gastroenterology 57:4, pages 424-431.
Read now

Articles from other publishers (8)

Yuran Cao, Jingjing Wang, Xingyu Tang, Yan Tian, Jicheng Yu, Hong Liang, Jufang Wu, Yuancheng Chen, Guoying Cao & Jing Zhang. (2024) Pharmacokinetic and safety profiles of mesalazine enema in healthy Chinese subjects: A single- and multiple-dose study. PLOS ONE 19:2, pages e0296940.
Crossref
Hongyun Xu, Chunyu Wu, Danning Wang & Haiqiang Wang. (2024) Alleviating effect of Nexrutine on mucosal inflammation in mice with ulcerative colitis: Involvement of the RELA suppression. Immunity, Inflammation and Disease 12:1.
Crossref
Yurianna Santos & Arturo P Jaramillo. (2023) Effectiveness of Mesalamine in Patients With Ulcerative Colitis: A Systematic Review. Cureus.
Crossref
Kristine Paridaens, John R Fullarton & Simon P L Travis. (2023) Efficacy of oral prolonged‐release mesalazine in moderately active ulcerative colitis. JGH Open 7:7, pages 516-519.
Crossref
Vlasta Oršić Frič, Vladimir Borzan, Andrej Borzan, Izabela Kiš, Branko Dmitrović & Ivana Roksandić-Križan. (2023) Colitis as the Main Presentation of COVID-19: A Case Report. Medicina 59:3, pages 576.
Crossref
Claudia Fuxman, Beatriz Sicilia, María Eugenia Linares, Santiago García-López, Ramiro González Sueyro, Yago González-Lamac, Yamile Zabana, Joaquín Hinojosa, Manuel Barreiro-de Acosta, Domingo Balderramo, Deborah Balfour, Maricel Bellicoso, Pamela Daffra, Daniela Morelli, Marina Orsi, Astrid Rausch, Orlando Ruffinengo, Martín Toro, Alicia Sambuelli, Abel Novillo, Fernando Gomollón & Juan Andrés De Paula. (2023) Guía GADECCU 2022 para el tratamiento de la colitis ulcerosa. Adaptación y actualización de la Guía GETECCU 2020. Gastroenterología y Hepatología 46, pages S1-S56.
Crossref
Gang Guo, Zhaobang Tan, Yaping Liu, Feiyu Shi & Junjun She. (2022) The therapeutic potential of stem cell-derived exosomes in the ulcerative colitis and colorectal cancer. Stem Cell Research & Therapy 13:1.
Crossref
Si-min Chen, Guang-ye Ji, Xu-ran Liu, Meng-juan Yang, Yi-nuo Zhang, Jing Cao & Yang Pan. (2022) Efficacy of integrated traditional Chinese and Western medicine on ulcerative colitis: A systematic review and meta-analysis. Pharmacological Research - Modern Chinese Medicine 4, pages 100145.
Crossref